These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

284 related articles for article (PubMed ID: 31779058)

  • 41. Recent approaches targeting beta-amyloid for therapeutic intervention of Alzheimer's disease.
    Cho JE; Kim JR
    Recent Pat CNS Drug Discov; 2011 Sep; 6(3):222-33. PubMed ID: 21834780
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Blood-Brain Barrier Dysfunction and the Pathogenesis of Alzheimer's Disease.
    Yamazaki Y; Kanekiyo T
    Int J Mol Sci; 2017 Sep; 18(9):. PubMed ID: 28902142
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Peripheral insulin-sensitizer drug metformin ameliorates neuronal insulin resistance and Alzheimer's-like changes.
    Gupta A; Bisht B; Dey CS
    Neuropharmacology; 2011 May; 60(6):910-20. PubMed ID: 21277873
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Ocular indicators of Alzheimer's: exploring disease in the retina.
    Hart NJ; Koronyo Y; Black KL; Koronyo-Hamaoui M
    Acta Neuropathol; 2016 Dec; 132(6):767-787. PubMed ID: 27645291
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Active full-length DNA Aβ
    Rosenberg RN; Fu M; Lambracht-Washington D
    Alzheimers Res Ther; 2018 Nov; 10(1):115. PubMed ID: 30454039
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Oleocanthal-rich extra-virgin olive oil enhances donepezil effect by reducing amyloid-β load and related toxicity in a mouse model of Alzheimer's disease.
    Batarseh YS; Kaddoumi A
    J Nutr Biochem; 2018 May; 55():113-123. PubMed ID: 29413486
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Extending Arms of Insulin Resistance from Diabetes to Alzheimer's Disease: Identification of Potential Therapeutic Targets.
    Gupta S; Singhal NK; Ganesh S; Sandhir R
    CNS Neurol Disord Drug Targets; 2019; 18(3):172-184. PubMed ID: 30430949
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Chronic hyperglycemia induced via the heterozygous knockout of Pdx1 worsens neuropathological lesion in an Alzheimer mouse model.
    Guo C; Zhang S; Li JY; Ding C; Yang ZH; Chai R; Wang X; Wang ZY
    Sci Rep; 2016 Jul; 6():29396. PubMed ID: 27406855
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Characterization of Impaired Cerebrovascular Structure in APP/PS1 Mouse Brains.
    Ahn KC; Learman CR; Dunbar GL; Maiti P; Jang WC; Cha HC; Song MS
    Neuroscience; 2018 Aug; 385():246-254. PubMed ID: 29777753
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Amyloid-beta and phosphorylated tau in post-mortem Alzheimer's disease retinas.
    den Haan J; Morrema THJ; Verbraak FD; de Boer JF; Scheltens P; Rozemuller AJ; Bergen AAB; Bouwman FH; Hoozemans JJ
    Acta Neuropathol Commun; 2018 Dec; 6(1):147. PubMed ID: 30593285
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Fighting Alzheimer's disease and type 2 diabetes: pathological links and treatment strategies.
    Dai Y; Kamal MA
    CNS Neurol Disord Drug Targets; 2014 Mar; 13(2):271-82. PubMed ID: 24059324
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Gut dysbiosis, insulin resistance and Alzheimer's disease: review of a novel approach to neurodegeneration.
    Lazar E; Sherzai A; Adeghate J; Sherzai D
    Front Biosci (Schol Ed); 2021 Jun; 13(1):17-29. PubMed ID: 34256527
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Metabolic links between diabetes and Alzheimer's disease.
    Maher PA; Schubert DR
    Expert Rev Neurother; 2009 May; 9(5):617-30. PubMed ID: 19402773
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Understanding molecular mechanisms of proteolysis in Alzheimer's disease: progress toward therapeutic interventions.
    Higuchi M; Iwata N; Saido TC
    Biochim Biophys Acta; 2005 Aug; 1751(1):60-7. PubMed ID: 16054018
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Chronic adiponectin deficiency leads to Alzheimer's disease-like cognitive impairments and pathologies through AMPK inactivation and cerebral insulin resistance in aged mice.
    Ng RC; Cheng OY; Jian M; Kwan JS; Ho PW; Cheng KK; Yeung PK; Zhou LL; Hoo RL; Chung SK; Xu A; Lam KS; Chan KH
    Mol Neurodegener; 2016 Nov; 11(1):71. PubMed ID: 27884163
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Amyloid β oligomers in Alzheimer's disease pathogenesis, treatment, and diagnosis.
    Viola KL; Klein WL
    Acta Neuropathol; 2015 Feb; 129(2):183-206. PubMed ID: 25604547
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Effects of the superoxide dismutase/catalase mimetic EUK-207 in a mouse model of Alzheimer's disease: protection against and interruption of progression of amyloid and tau pathology and cognitive decline.
    Clausen A; Xu X; Bi X; Baudry M
    J Alzheimers Dis; 2012; 30(1):183-208. PubMed ID: 22406441
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Neuroprotective effects of geniposide on Alzheimer's disease pathology.
    Liu W; Li G; Hölscher C; Li L
    Rev Neurosci; 2015; 26(4):371-83. PubMed ID: 25879319
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Cerebrovascular pathology and amyloid plaque formation in Alzheimer's disease.
    Lee CW; Shih YH; Kuo YM
    Curr Alzheimer Res; 2014 Jan; 11(1):4-10. PubMed ID: 24251391
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Shared links between type 2 diabetes mellitus and Alzheimer's disease: A review.
    Mittal K; Katare DP
    Diabetes Metab Syndr; 2016; 10(2 Suppl 1):S144-9. PubMed ID: 26907971
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 15.